KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moodys (MCO) Gains from Investment Securities (2016 - 2025)

Moodys (MCO) has disclosed Gains from Investment Securities for 17 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 16.67% to $7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $99.0 million, a 8.79% increase, with the full-year FY2025 number at $99.0 million, up 8.79% from a year prior.
  • Gains from Investment Securities was $7.0 million for Q4 2025 at Moodys, up from $4.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $58.0 million in Q1 2022 to a low of $1.0 million in Q4 2021.
  • A 5-year average of $21.6 million and a median of $13.0 million in 2023 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 200.0% in 2021; the steepest drop was 66.67% in 2021.
  • Moodys' Gains from Investment Securities stood at $1.0 million in 2021, then surged by 100.0% to $2.0 million in 2022, then surged by 100.0% to $4.0 million in 2023, then skyrocketed by 50.0% to $6.0 million in 2024, then rose by 16.67% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for MCO's Gains from Investment Securities are $7.0 million (Q4 2025), $4.0 million (Q3 2025), and $35.0 million (Q2 2025).